Form 4 for PBH Prestige Consumer Healthcare Inc.
Accepted 2022-08-03 00:00:00 ET · period of report 2022-08-02 · accession 0001104659-22-085713 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-08-03 | 2022-08-02 | PBH | COUGHLIN CHRISTOPHER J | Dir | A - Grant | $0.00 | +2,495 | 13.2K | +23% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.01 per share | 2022-08-02 | A | A | 2,495 | $0.00 | 13,218 | D | — | — | (F1) The Reporting Person received 2,495 restricted stock units (equal to $150,000 divided by the closing stock price of $60.12on August 2, 2022) in connection with the Issuer's director compensation program. The restricted stock units vest on August 2, 2023. |